Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury


Introduction Traumatic brain injury (TBI) remains a leading cause of disability and death among young people in China. Unfortunately, no specific pharmacological agents to block the progression of secondary brain injury have been approved for clinical treatment. Recently, neuroprotective effects of erythropoietin (EPO) have been demonstrated in addition to… (More)
DOI: 10.1002/brb3.827


  • Presentations referencing similar topics